Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-02-01 @ 7:10 PM
Study NCT ID:
NCT00425750
Status:
COMPLETED
Last Update Posted:
2011-11-16
First Post:
2007-01-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | stage IV squamous cell carcinoma of the lip and oral … | View |
| None | recurrent squamous cell carcinoma of the lip and oral cavity | View |
| None | stage IV squamous cell carcinoma of the oropharynx | View |
| None | recurrent squamous cell carcinoma of the oropharynx | View |
| None | stage IV squamous cell carcinoma of the hypopharynx | View |
| None | recurrent squamous cell carcinoma of the hypopharynx | View |
| None | stage IV squamous cell carcinoma of the larynx | View |
| None | recurrent squamous cell carcinoma of the larynx | View |